PITTSBURGH, Aug. 2, 2016 /PRNewswire/ -- ChemImage Sensor Systems (CISS™) announced the launch of a new Presumptive Identification feature for their VeroVision™ Mail Screener product. The VeroVision Mail Screener, which was introduced to the corrections market in April 2015, is a non-contact imaging device designed to detect concealed narcotics that are sent through the mail to inmates. CISS will debut the VeroVision Mail Screener's presumptive identification capability at the upcoming American Correctional Association 146th Congress of Corrections in Boston, MA, from August 5th -10th, 2016. The VeroVison Mail Screener's current detection and new presumptive identification capabilities will be demonstrated at the CISS exhibit at booth #405.
The ChemImage VeroVision Mail Screener features a simple, one-click user interface that allows the operator to quickly and efficiently scan mail. Within seconds, the presence of an illicit drug and/or common cutting agent that may be hidden in a mail item is confirmed. And now, not only will the system detect the illicit material; it will give you a presumptive identification of what that material is. These detections/presumptive identifications are presented to the user in a simple interface which allows for report generation, inclusive of images.
In addition to demonstrating the Mail Screener's detection capability and officially introducing its Presumptive Identification capability, as a part of the expo, ChemImage Sensor Systems is hosting a hospitality event after sessions on Monday, August 8th, 2016 at Kings in Boston. Attendees to the expo have been invited to the CISS event for a fun-filled night of games, amusement, and other surprises to celebrate our continued success with the VeroVision Mail Screener and the launch of the Presumptive Identification feature.
For more information on the VeroVision Mail Screener product or ChemImage Sensor Systems you can visit them during the ACA conference or on their website www.cisensorsystems.com.
About ChemImage Sensor Systems
ChemImage Sensor Systems (CISS™) develops innovative standoff chemical imaging sensors that make our world healthier and safer by utilizing patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of drugs, chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens. For more information, visit www.cisensorsystems.com
ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art chemical imaging sensors make our world healthier and safer through many scientific applications, including defense, security, pharmaceuticals, forensic science and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems. For more information, visit www.chemimage.com
ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chemimage-sensor-systems-launches-presumptive-identification-feature-for-verovision-mail-screener-300308098.html
SOURCE ChemImage Corporation